Management of infections due to resistant enterococci: A review of therapeutic options

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 2, 1997, Pages 161-170

  Landman, David ^a   Quale, John M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIINFECTIVE AGENT; CEFTRIAXONE; CHLOROORIENTICIN A; CIPROFLOXACIN; CLAVULANIC ACID; CLINAFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; FOSFOMYCIN; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; MINOCYCLINE; NOVOBIOCIN; PENICILLIN DERIVATIVE; PIPERACILLIN; RAMOPLANIN; RIFAMPICIN; SITAFLOXACIN; STREPTOMYCIN; SULBACTAM; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIUM; CLINICAL TRIAL; ENTEROCOCCUS; HUMAN; INCIDENCE; INFECTION RATE; MEDICAL DECISION MAKING; MULTIDRUG RESISTANCE; NONHUMAN; REVIEW; TREATMENT PLANNING;

AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS; GLYCOPEPTIDES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; PENICILLINS;

EID: 0030868151     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.2.161     Document Type: Review

References (104)

1. Maki, D. G. & Agger, W. A. (1988). Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine 67, 248-69.
2. Gullberg, R. M., Homann, S. R. & Phair, J. P. (1989). Enterococcal bacteremia: analysis of 75 episodes. Reviews of Infectious Diseases 11, 74-85.
3. Watanakunakorn, C. & Patel, R. (1993). Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin. Clinical Infectious Diseases 17, 74-8.
4. Wilson, W. R., Karchmer, A. W., Dajani, A. S., Taubert, K. A., Bayer, A., Kaye, D. et al. (1995). Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. Journal of the American Medical Association 274, 1706-13.
5. Geraci, J. E. & Martin, W. J. (1954). Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis: clinical, pathologic and therapeutic consideration of 33 cases. Circulation 10, 173-94.
6. Koenig, M. G. & Kaye, D. (1961). Enterococcal endocarditis. Report of nineteen cases with long-term follow-up data. New England Journal of Medicine 264, 257-64.
7. Mandell, G. L., Kaye, D., Levison, M. E. & Hook, E. W. (1970). Enterococcal endocarditis: an analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Archives of Internal Medicine 125, 258-64.
8. Herzstein, J., Ryan, J. L., Mangi, R. J., Greco, T. P. & Andriole, V. T. (1984). Optimal therapy for enterococcal endocarditis. American Journal of Medicine 76, 186-91.
9. Weinstein, A. J. & Moellering, R. C. (1973). Penicillin and gentamicin therapy for enterococcal infections. Journal of the American Medical Association 223, 1030-2.
10. Serra, P., Brandimarte, C., Martino, P., Carlone, S. & Giunchi, G. (1977). Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies. Archives of Internal Medicine 137, 1562-7.
11. Wilson, W. R., Wilkowske, C. J., Wright, A. J., Sande, M. A. & Geraci, J. E. (1984). Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Annals of Internal Medicine 100, 816-23.
12. Spiegel, C. A. & Huycke, M. (1989). Endocarditis due to streptomycin-susceptible Enterococcus faecalis with high-level gentamicin resistance. Archives of Internal Medicine 149, 1873-5.
13. Grayson, M. L., Eliopoulos, G. M., Wennersten, C. B., Ruoff, K. L., De Girolami, P. C., Ferraro, M. J. et al. (1991). Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrobial Agents and Chemotherapy 35, 2180-4.
14. Gordon, S., Swenson, J., Facklam, R., Pigott, N., Hill, B., Cooksey, R. et al. (1989). A multicenter study of the epidemiology of enterococcal infections. In Program and Abstracts of the Twenty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, TX, 1989. Abstract 790, p. 233. American Society for Microbiology, Washington, DC.
15. Hindes, R. G., Willey, S. H., Eliopoulos, G. M., Rice, L. B., Eliopoulos, C. T., Murray, B. E. et al. (1989). Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin. Antimicrobial Agents and Chemotherapy 33, 1019-22.
16. Lavoie, S. R., Wong, E. S., Coudron, P. E., Williams, D. S. & Markowitz, S. M. (1993). Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 37, 1447-51.
17. Hellinger, W. C., Rouse, M. S., Rabadan, P. M., Henry, N. K., Steckelberg, J. M. & Wilson, W. R. (1992). Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci. Antimicrobial Agents and Chemotherapy 36, 1272-5.
18. Pelletier, L. L. & Petersdorf, R. G. (1977). Infective endocarditis: a review of 125 cases from the University of Washington hospitals, 1963-72. Medicine 56, 287-313.
19. Libertin, C. R. & McKinley, K. M. (1990). Gentamicin-resistant enterococcal endocarditis: the need for routine screening for high-level resistance to aminoglycosides. Southern Medical Journal 83, 458-60.
20. Lipman, M. L. & Silva, J. (1989). Endocarditis due to Streptococcus faecalis with high-level resistance to gentamicin. Reviews of Infectious Diseases 11, 325-8.
21. Kathpalia, S., Lolans, V., Levandowski, R. & Jackson, G. G. (1984). Resistance to all aminoglycoside antibiotics in enterococcal endocarditis. Clinical Research 32, A372.
22. Fernandez-Guerrero, M. L., Barros, C., Rodriguez Tudela, J. L., Fernandez Roblas, R. & Soriano, F. (1988). Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis. European Journal of Clinical Microbiology & Infectious Diseases 7, 525-7.
23. Holliman, R. & Smyth, E. (1989). Gentamicin-resistant enterococci and endocarditis. Postgraduate Medical Journal 65, 390-3.
24. Rice, L. B., Calderwood, S. B., Eliopoulos, G. M., Farber, B. F. & Karchmer, A. W. (1991). Enterococcal endocarditis: a comparison of prosthetic and native valve disease. Reviews of Infectious Diseases 13, 1-7.
25. Patterson, J. E., Colodny, S. M. & Zervos, M. J. (1988). Serious infection due to beta-lactamase-producing Streptocococcus faecalis with high-level resistance to gentamicin. Journal of Infectious Diseases 158, 1144-5.
26. Mobarakai, N., Landman, D. & Quale, J. M. (1994). In-vitro activity of trospectomycin, a new aminocyclitol antibiotic, against multidrug-resistant Enterococcus faecium. Journal of Antimicrobial Chemotherapy 33, 319-21.
27. Murray, B. E. & Mederski-Samaroj, B. (1983). Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. Journal of Clinical Investigation 72, 1168-71.
28. Markowitz, S. M., Wells, V. D., Williams, D. S., Stuart, C. G., Coudron, P. E. & Wong, E. S. (1991). Antimicrobial susceptibility and molecular epidemiology of beta-lactamase-producing, aminoglycoside-resistant isolates of Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 35, 1075-80.
29. Rhinehart, E., Smith, N. E., Wennersten, C., Gorss, E., Freeman, J., Eliopoulos, G. M. et al. (1990). Rapid dissemination of β-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. New England Journal of Medicine 323, 1814-8.
30. Ingerman, M., Pitsakis, P. G., Rosenberg, A., Hessen, M. T., Abrutyn, E., Murray, B. E. et al. (1987). β-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis. Journal of Infectious Diseases 155, 1226-32.
31. Wells, V. D., Wong, E. S., Murray, B. E., Coudron, P. E., Williams, D. S. & Markowitz, S. M. (1992). Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Annals of Internal Medicine 116, 285-92.
32. Yao, J. D. C., Thauvin-Eliopoulos, C., Eliopoulos, G. M. & Moellering, R. C. (1990). Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin. Antimicrobial Agents and Chemotherapy 34, 827-30.
33. Ramos, M. C., Grayson, M. L., Eliopoulos, G. M. & Bayer, A. S. (1992). Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci. Antimicrobial Agents and Chemotherapy 36, 1864-9.
34. Schmit, J. L. (1992). Efficacy of teicoplanin for enterococcal infections: 63 cases and review. Clinical Infectious Diseases 15, 302-6.
35. Sapico, F. L., Canawati, H. N., Ginunas, V. J., Gilmore, D. S., Montgomerie, J. Z., Tuddenham, W. J. et al. (1989). Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? Journal of Clinical Microbiology 27, 2091-5.
36. Boyce, J. M., Opal, S. M., Potter-Bynoe, G., LaForge, R. G., Zervos, M. J., Furtado, G. et al. (1992). Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrobial Agents and Chemotherapy 36, 1032-9.
37. Oster, S. E., Chirurgi, V. A., Goldberg, A. A., Aiken, S. & McCabe, R. E. (1990). Ampicillin-resistant enterococcal species in an acute-care hospital. Antimicrobial Agents and Chemotherapy 34, 1821-3.
38. Torres, C., Tenorio, C., Lantero, M., Gastanares, M. J. & Baquero, F. (1993). High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium. Antimicrobial Agents and Chemotherapy 37, 2427-31.
39. Bush, L. M., Calmon, J., Cherney, C. L., Wendeler, M., Pitsakis, P., Poupard, J. et al. (1989). High-level penicillin resistance among isolates of enterococci. Annals of Internal Medicine 110, 515-20.
40. Patterson, J. E., Sweeney, A. H., Simms, M., Carley, N., Mangi, R., Sabetta, J. et al. (1995). An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine 74, 191-200.
41. Centers for Disease Control and Prevention. (1993). Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. Morbidity and Mortality Weekly Report 42, 597-9.
42. Jordens, J. Z., Bates, J. & Griffiths, D. T. (1994). Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. Journal of Antimicrobial Chemotherapy 34, 515-28.
43. Morris, J. G., Shay, D. K., Hebden, J. N., McCarter, R. J., Perdue, B. E., Jarvis, W. et al. (1995). Enterococci resistant to multiple antimicrobial agents including vancomycin. Annals of Internal Medicine 123, 250-9.
44. Quale, J., Landman, D., Atwood, E., Kreiswirth, B., Willey, B. M., Ditore, V. et al. (1996). Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. American Journal of Infection Control 24, 372-9.
45. Venditti, M., Biavasco, F., Varaldo, P. E., Macchiarelli, A., De Biase, L., Marino, B. et al. (1993). Catheter-related endocarditis due to glycopeptide-resistant Enterococcus faecalis in a transplanted heart. Clinical Infectious Diseases 17, 524-5.
46. Green, M., Barbadora, K. & Michaels, M. (1991). Recovery of vancomycin-resistant Gram-positive cocci from pediatric liver transplant recipients. Journal of Clinical Microbiology 29, 2503-6.
47. Landman, D., Quale, J. M., Mobarakai, N. & Zaman, M. M. (1995). Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium. Journal of Antimicrobial Chemotherapy 36, 253-8.
48. Landman, D., Quale, J. M., Burney, S., Kreiswirth, B. & Willey, B. M. (1996). Treatment of experimental endocarditis caused by multidrug resistant Enterococcus faecium with ramoplanin and penicillin. Journal of Antimicrobial Chemotherapy 37, 323-9.
49. Montecalvo, M. A., Horowitz, H., Gedris, C., Carbonaro, C., Tenover, F. C., Issah, A. et al. (1994). Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrobial Agents and Chemotherapy 38, 1363-7.
50. Fantin, B., Leclercq, R., Arthur, M., Duval, J. & Carbon, C. (1991). Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium. Antimicrobial Agents and Chemotherapy 35, 1570-5.
51. Nicolau, D. P., Marangos, M. N., Nightingale, C. H., Quintiliani, R., Cooper, B. W., Courvalin, P. et al. (1994). Efficacy of vancomycin and teicoplanin in experimental endocarditis using isogenic vm susceptible and VanB-type resistant isolates of E. faecalis. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract B73, p. 150. American Society for Microbiology, Washington, DC.
52. Sahm, D. G., Kissinger, J., Gilmore, M. S., Murray, P. R., Mulder, R., Solliday, J. et al. (1989). In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 33, 1588-91.
53. Losonsky, G. A., Wolf, A., Schwalbe, R. S., Nataro, J., Gibson, C. B. & Lewis, E. W. (1994). Successful treatment of meningitis due to multiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents. Clinical Infectious Diseases 19, 163-5.
54. Hayden, M. K., Trenholme, G. M., Schultz, J. E. & Sahm, D. F. (1993). In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. Journal of Infectious Diseases 167, 1224-7.
55. Caron, F., Carbon, C. & Gutmann, L. (1991). Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin-and highly glycopeptide-resistant isolate of Enterococcus faecium. Journal of Infectious Diseases 164, 888-93.
56. Leclercq, R., Bingen, E., Su, Q. H., Lambert-Zechovski, N., Courvalin, P. & Duval, J. (1991). Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci. Antimicrobial Agents and Chemotherapy 35, 92-8.
57. Shlaes, D. M., Etter, L. & Gutmann, L. (1991). Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin. Antimicrobial Agents and Chemotherapy 35, 776-9.
58. Caron, F., Pestel, M., Kitzis, M. D., Lemeland, J. F., Humbert, G. & Gutmann, L. (1995). Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium. Journal of Infectious Diseases 171, 106-12.
59. Cercenado, E., Eliopoulos, G. M., Wennersten, C. B. & Moellering, R. C. (1992). Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci. Antimicrobial Agents and Chemotherapy 36, 2201-3.
60. Fraimow, H. S. & Venuti, E. (1992). Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy 36, 1563-6.
61. Green, M., Binczewski, B., Pasculle, A. W., Edmund, M., Barbadora, K., Kusne, S. et al. (1993). Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations. Antimicrobial Agents and Chemotherapy 37, 1238-42.
62. Grimm, H. (1985). Antibacterial activity of 19 antimicrobial agents and kill kinetics of ciprofloxacin plus ampicillin against gentamicin-resistant and high-level-resistant enterococci. In Recent Advances in Chemotherapy, Antimicrobial Section 2 (Ishigami, J., Ed.), pp. 1571-2. University of Tokyo Press, Tokyo.
63. Fernandez-Guerrero, M., Rouse, M. S., Henry, N. K., Geraci, J. E. & Wilson, W. R. (1987). In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis. Antimicrobial Agents and Chemotherapy 31, 430-3.
64. Eliopoulos, G. M., Willey, S., Murray, B. E. & Moellering, R. C. (1989). Ciprofloxacin in experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant strain of Enterococcus faecalis. Reviews of Infectious Diseases 11, Suppl. 5, S1210-1.
65. Frieden, T. R., Munsiff, S. S., Low, D. E., Willey, B. M., Williams, G., Faur, Y. et al. (1993). Emergence of vancomycin-resistant enterococci in New York City. Lancet 342, 76-9.
66. Landman, D., Mobarakai, N. K. & Quale, J. M. (1993). Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrobial Agents and Chemotherapy 37, 1904-8.
67. Whitman, M. S., Pitsakis, P. G., Zausner, A., Livornese, L. L., Osborne, A. J., Johnson, C. C. et al. (1993). Antibiotic treatment of experimental endocarditis due to vancomycin-and ampicillin-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy 37, 2069-73.
68. Livornese, L. L., Dias, S., Samel, C., Romanowski, B., Taylor, S., May, P. et al. (1992). Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Annals of Internal Medicine 117, 112-6.
69. French, P., Venuti, E. & Fraimow, H. S. (1993). In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium. Antimicrobial Agents and Chemotherapy 37, 2736-9.
70. Quale, J. M., Landman, D. & Mobarakai, N. (1994). Treatment of experimental endocarditis due to multidrug resistant Enterococcus faecium with ciprofloxacin and novobiocin. Journal of Antimicrobial Chemotherapy 34, 797-802.
71. Linden, P. K., Pasculle, A. W., Manez, R., Kramer, D. J., Fung, J. J., Pinna, A. D. et al. (1996). Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clinical Infectious Diseases 22, 663-70.
72. Schaberg, D. R., Dillon, W. I., Terpenning, M. S., Robinson, K. A., Bradley, S. F. & Kauffman, C. A. (1992). Increasing resistance of enterococci to ciprofloxacin. Antimicrobial Agents and Chemotherapy 36, 2533-5.
73. Montecalvo, M. A., Horowitz, H., Wormser, G. P., Seiter, K. & Carbonaro, C. A. (1995). Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy 39, 794.
74. Moreno, F., Jorgensen, J. H. & Weiner, M. H. (1994). An old antibiotic for a new multiple-resistant Enterococcus faecium? Diagnostic Microbiology and Infectious Disease 20, 41-3.
75. Lam, S., Singer, C., Tucci, V., Morthland, V. H., Pfaller, M. A. & Isenberg, H. D. (1995). The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. American Journal of Infection Control 23, 170-80.
76. Hardalo, C., Rigsby, M., Chen, L., Dykewicz, C., Elmore, J., Nagy-Agren, S. et al. (1993). Chloramphenicol treatment of resistant Enterococcus faecium infections. In Program and Abstracts of the Thirty-First Infectious Diseases Society of America Annual Meeting, New Orleans, LA, 1993. Abstract 110, p. 20-A. Infectious Diseases Society of America, Washington, DC.
77. Lukashok, S. A. & Casadevall, A. (1995). Persistent vancomycin-resistant Enterococcus faecium bacteremia. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract J74, p. 270. American Society for Microbiology, Washington, DC.
78. Norris, A. H., Reilly, J. P., Edelstein, P. H., Brennan, P. J. & Schuster, M. G. (1995). Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clinical Infectious Diseases 20, 1137-44.
79. Hamilton-Miller, J. M. T. (1989). Antibiotic treatment of enterococcal infection. Antimicrobial Agents and Chemotherapy 33, 989.
80. Najjar, A. & Murray, B. E. (1987). Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci. Antimicrobial Agents and Chemotherapy 31, 808-10.
81. Grayson, M. L., Thauvin-Eliopoulos, C., Eliopoulos, G. M., Yao, J. D. C., DeAngelis, D. V., Walton, L. et al. (1990). Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. Antimicrobial Agents and Chemotherapy 34, 1792-4.
82. Chenoweth, C. E., Robinson, K. A. & Schaberg, D. R. (1990). Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis. Antimicrobial Agents and Chemotherapy 34, 1800-2.
83. Caron, F., Pestel, M., Gutmann, L., Humbert, G. & Lemeland, J. F. (1995). Synergy between ceftriaxone and fosfomycin in the treatment of an experimental endocarditis due to vancomycin-susceptible or vancomycin-resistant Enterococcus faecium. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract B47, p. 34. American Society for Microbiology, Washington, DC.
84. Burney, S., Landman, D. & Quale, J. M. (1994). Activity of clinafloxacin against multidrug-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy 38, 1668-70.
85. Zaman, M. M., Landman, D., Burney, S. & Quale, J. M. (1996). Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxacin and penicillin. Journal of Antimicrobial Chemotherapy 37, 127-32.
86. Korten, V., Tomayko, J. F. & Murray, B. E. (1994). Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against Gram-positive cocci. Antimicrobial Agents and Chemotherapy 38, 611-5.
87. Eliopoulos, G. M., Wennersten, C. B., Cole, G. & Moellering, R. C. (1994). In vitro activities of two glycylcyclines against Gram-positive bacteria. Antimicrobial Agents and Chemotherapy 38, 534-41.
88. Bingen, E., Lambert-Zechovsky, N., Leclercq, R., Doit, C. & Mariani-Kurkdjian, P. (1990). Bactericidal activity of vancomycin, daptomycin, ampicillin and aminoglycosides against vancomycin-resistant Enterococcus faecium. Journal of Antimicrobial Chemotherapy 26, 619-26.
89. Mobarakai, N., Quale, J. M. & Landman, D. (1994). Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy 38, 385-7.
90. Caron, F., Kitzis, M. D., Gutmann, L., Cremieux, A. C., Maziere, B., Vallois, J. M. et al. (1992). Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium. Antimicrobial Agents and Chemotherapy 36, 2611-6.
91. Nicas, T. I., Cole, C. T., Preston, D. A., Schabel, A. A. & Nagarajan, R. (1989). Activity of glycopeptides against vancomycin-resistant Gram-positive bacteria. Antimicrobial Agents and Chemotherapy 33, 1477-81.
92. Breen, J. D., Thauvin-Eliopoulos, C., Eliopoulos, G. M. & Moellering, R. C. (1995). Activity of new semisynthetic glycopeptides against vancomycin resistant organisms. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F253, p. 157. American Society for Microbiology, Washington, DC.
93. Cooper, R. D. G., Mullen, D. L., Butler, T. F., Lin, Y., Snyder, N. J., Zweifel, M. J. et al. (1995). Discovery of new semisynthetic glycopeptides active against vancomycin-resistant enterococci. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F242, p. 155. American Society for Microbiology, Washington, DC.
94. Boylan, C. J., Nicas, T. I., Preston, D. A., Zeckner, D. L., Boyll, B. J., Raab, P. A. et al. (1995). Efficacy of semisynthetic glycopeptides active against vancomycin-resistant enterococci in a mouse infection model. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F255, p. 157. American Society for Microbiology, Washington, DC.
95. Bostic, G., Perri, M. B., Thal, L. A. & Zervos, M. J. (1995). Comparative in-vitro and bactericidal activity of oxazolidinone antibiotics against multi-drug resistant enterococci. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F219, p. 151. American Society for Microbiology, Washington, DC.
96. Eliopoulos, G. M., Wennersten, C. B. & Moellering, R. C. (1995). Activities of new oxazolidinone antimicrobials against enterococci. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F217, p. 151. American Society for Microbiology, Washington, DC.
97. Collins, L. A., Malanoski, G. J., Eliopoulos, G. M., Wennersten, C. B., Ferraro, M. J. & Moellering, R. C. (1993). In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant Gram-positive organisms. Antimicrobial Agents and Chemotherapy 37, 598-601.
98. Mahayni, R., Perri, M. B., Dembry, L. M. & Zervos, M. J. (1994). Comparative in-vitro and bactericidal activity of RP59500 (quinupristin/dalfopristin) against multi-drug resistant E. faecium. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract E3, p. 27. American Society for Microbiology, Washington, DC.
99. Hill, R. L. R., Smith, C. & Casewell, M. W. (1995). Bactericidal and inhibitory activity of RP59500 (quinupristin/dalfopristin) and its components against vancomycin-and gentamicin-resistant Enterococcus faecium. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract E118, p. 106. American Society for Microbiology, Washington, DC.
100. Lynn, W. A., Clutterbuck, E., Want, S., Markides, V., Lacey, S., Rogers, T. R. et al. (1994). Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin. Lancet 344, 1025-6.
101. Linden, P., Pasculle, A. W., Riddler, S., Kusne, S., Silverman, A. & Dean, J. (1994). Quinupristin/dalfopristin (RP59500) for the treatment of serious infection due to high level vancomycin resistant Enterococcus faecium. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract M68, p. 261. American Society for Microbiology, Washington, DC.
102. Furlong, W. B. & Bompart, F. (1994). Therapy for enterococci with vanA/vanB resistance patterns using RP59500 (quinupristin/dalfopristin). In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract M66, p. 261. American Society for Microbiology, Washington, DC.
103. National Committee for Clinical Laboratory Standards. (1993). Performance Standards for Antimicrobial Disk Susceptibility Tests - Fifth Edition; Approved Standard M2-A5. NCCLS, Villanova, PA.
104. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition; Approved Standard M7 A3. NCCLS, Villanova, PA.